-
Min Investment
-
$250
-
Offering Date
-
April 06, 2023
-
Expected Close Date
-
March 03, 2024
-
Target Raise
-
$250.00K-$3.77M
-
No. Investors
-
246
-
Security Price
-
$1
-
Valuation
-
$85,000,000
- Number of Employees
- 12
- Cash
- $211,211
- Revenue
- $1,961,323
- Short Term Debt
- $4,799,773
- Cost of Goods
- $2,019,568
- Long Term Debt
- $11,586,212
- Net Income
- $-11,458,731
Company Description
Perfomance
Key Deal Facts
Q1 2024: Supersapiens enters US market with a focus on diabetes
Glucose monitoring platform for optimizing health & performance
Insights for metabolic health via glucose, first launched in Europe
Partnered with a market leader to enhance US diabetes management
World's largest glucose dataset (non-diabetic): 1B+ data points
Trusted by Olympians, F1, UEFA, NBA, PGA, NFL, NHL, MLB, TDF, Ironman
Seamlessly integrates with Apple Health, Oura, Garmin, Wahoo, and others
Management Team / Advisory Board Bios
Phil Southerland
CEO & Founder
An experienced CEO, entrepreneur, public speaker, and global diabetes ambassador. Founded Team Novo Nordisk Pro Cycling Team, & the non-profit Team Type 1 Foundation. Recognized by the United Nations, WHO, World Bank and more.
Jay Robbins
CFO & Co-Founder
Jay has over 20 years of experience in finance, accounting, and operations in several different businesses. Before he joined Phil to start Supersapiens, he was a partner with a large CPA firm working with fast growing Private Equity backed companies.
Fitzalan Crowe
Chief of Staff & Co-Founder
Fitzalan is a seasoned marketing executive with more than 20 years of experience in strategic communications, executive positioning, public relations, athlete management, and earned media.
